Water and Coffee Intervention in Humans
1 other identifier
interventional
39
1 country
1
Brief Summary
39 healthy subjects without medication (except oral contraceptives) aged 20-70 years are recruited via advertisements or through telephone contacts with individuals that had previously participated in population-based cohort studies in Malmö. All subjects are exposed to three different intervention procedures; water and coffee loads (acutely and chronically), or no change from usual fluid intake (as a time-control), respectively in randomized order. The daily intake of coffee or water will amount to 3 L of water and 1 L of coffee, respectively for one week each. The three interventions (water, coffee and control), are separated by three weeks of normal fluid intake as a wash-out period. By testing if simple life style interventions, i.e., increased water or coffee intake, may affect vasopressin secretion, evaluated as copeptin, we will increase the knowledge as to whether such life style induced changes of copeptin may in turn lead to effects on glucose tolerance as well as on other cardiometabolic risk factors previously shown to be associated with high copeptin level. Thus, the study will lead to further understanding about vasopressin and copeptin release and how life style manipulation of the vasopressin system may influence glucose metabolism and other cardiometabolic risk factors in healthy individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2016
CompletedFirst Submitted
Initial submission to the registry
November 22, 2023
CompletedFirst Posted
Study publicly available on registry
December 11, 2023
CompletedDecember 11, 2023
November 1, 2023
5.1 years
November 22, 2023
December 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1 week result on plasma copeptin
Change ("∆-value") between plasma copeptin value (pmol/L) at end of control week and post-intervention values will be calculated. Significance of differences between each intervention and the time-control will be tested using paired t-test or Wilcoxon's paired rank test, depending on normality of distributions.
7 days
Secondary Outcomes (9)
1 week result on plasma glucose
7 days
1 week result on plasma insulin
7 days
1 week result on plasma glucagon
7 days
1 week result on plasma C-reactive protein
7 days
1 week result on plasma creatinine
7 days
- +4 more secondary outcomes
Study Arms (3)
Water
EXPERIMENTALAt intervention day 1, during a maximum time period of 20 minutes, subjects will ingest 1 L of water (still bottled water) to map the acute water effect on the vasopressin marker copeptin (repeated blood sampling every 30 minutes for 4 hours). Day 1 then continues with the rest of the daily intake, i.e., 2 L of extra water (i.e. in addition to each subject's habitual food and fluid intake). Intervention day 2-7: 3 L extra water per day in addition to each subject's habitual food and fluid intake.
Coffee
EXPERIMENTALAt intervention day 1, during a maximum time period of 20 minutes, subjects will ingest 4 dL of coffee to map the acute coffee effect on the vasopressin marker copeptin (repeated blood sampling every 30 minutes for 4 hours). Day 1 then continues with the rest of the daily intake, i.e., 6dL of extra coffee (i.e. in addition to each subject's habitual food and fluid intake). Intervention day 2-7: 1 L extra coffee per day in addition to each subject's habitual food and fluid intake.
Control
EXPERIMENTALAt intervention day 1, during a maximum time period of 20 minutes, subjects will ingest just 10 ml of water to map the acute effect on the vasopressin marker copeptin (repeated blood sampling every 30 minutes for 4 hours). Day 1 then continues with each subject's habitual food and fluid intake. Intervention day 2-7: Each subject's habitual food and fluid intake.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy subjects Age 20-70 years
You may not qualify if:
- medication (except oral contraceptives) any type of acute illness any type of chronic illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Clinical research unit, Internal medicine department, Skåne University Hospital in Malmö
Malmo, 20502, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2023
First Posted
December 11, 2023
Study Start
January 1, 2011
Primary Completion
January 31, 2016
Study Completion
December 31, 2016
Last Updated
December 11, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share